ahlam1399
09-02-2016, 01:00 AM
New York comptroller says weak Mylan board fosters EpiPen ?debacle?
Sept 1 (Reuters) - New York City's comptroller on Thursdaycriticized "exorbitant" price increases for Mylan NV's EpiPen device and said weak board oversight of managementdecisions had undermined the company's reputation and stockprice.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=whd90vrjPv4:dOMH_e-E0y4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=whd90vrjPv4:dOMH_e-E0y4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=whd90vrjPv4:dOMH_e-E0y4:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=whd90vrjPv4:dOMH_e-E0y4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=whd90vrjPv4:dOMH_e-E0y4:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/whd90vrjPv4
Sept 1 (Reuters) - New York City's comptroller on Thursdaycriticized "exorbitant" price increases for Mylan NV's EpiPen device and said weak board oversight of managementdecisions had undermined the company's reputation and stockprice.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=whd90vrjPv4:dOMH_e-E0y4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=whd90vrjPv4:dOMH_e-E0y4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=whd90vrjPv4:dOMH_e-E0y4:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=whd90vrjPv4:dOMH_e-E0y4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=whd90vrjPv4:dOMH_e-E0y4:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/whd90vrjPv4